Our comprehensive guide hospitals information helps you quickly locate a hospital anywhere in the world. Our database contains in excess of 16,000 hospitals, making it one of the best places to find information on the hospital you are searching for. To assist you with locating a hospital, you can refine your search by selecting the country in which the hospital is located and choose to search by either hospital name, city/town or state/county.

 Home>> Metaglip (glipizide/metformin HCl)

Metaglip (glipizide/metformin HCl)

General Information

Metaglip combines glipizide and metformin HCl two prescribed oral antidiabetic agents in a single pill. These agents work in complementary fashion to improve blood sugar in patients with type 2 diabetes.

Metaglip is indicated as initial therapy, as an adjunct to diet and exercise, to improve glycemic control in patients with type 2 diabetes whose hyperglycemia cannot be satisfactorily managed with diet and exercise alone. Metaglip is also indicated as second-line therapy when diet, exercise, and initial treatment with a sulfonylurea or metformin do not result in adequate glycemic control in patients with type 2 diabetes.


Additional Information

For more information on Metaglip or Type-2 Diabetes, please contact The Bristol-Myers Squibb Web Site


Clinical Results

In clinical trials, Metaglip was shown to be more effective at lowering blood sugar levels than either glipizide or metformin used alone in patients with type 2 diabetes. In a 24-week, double-blind, active-controlled, multicenter international clinical trial, patients with type 2 diabetes, whose hyperglycemia was not adequately controlled with diet and exercise alone were randomized to receive initial therapy with glipizide (5 mg), metformin (500 mg), Metaglip (2.5 mg/250 mg), or Metaglip (2.5 mg/500 mg).

After 24 weeks, treatment with Metaglip resulted in significantly greater reduction in Hemoglobin A1c (HbA1c) compared to glipizide and to metformin therapy. Also, Metaglip therapy resulted in significant reductions in Fasting Plasma Glucose (FPG) versus metformin therapy. Increases above fasting glucose and insulin levels were determined at baseline and final study visits by measurement of plasma glucose and insulin for three hours following a standard mixed liquid meal. Treatment with Metaglip lowered the three-hour postprandial glucose AUC, compared to baseline, to a significantly greater extent than did the glipizide and the metformin therapies.


Mechanism of Action

Metaglip combines glipizide and metformin hydrochloride, two antihyperglycemic agents with complementary mechanisms of action, to improve glycemic control in patients with type 2 diabetes.

Glipizide appears to lower blood glucose acutely by stimulating the release of insulin from the pancreas, an effect dependent upon functioning beta cells in the pancreatic islets. Extrapancreatic effects may play a part in the mechanism of action of oral sulfonylurea hypoglycemic drugs.

Metformin hydrochloride is an antihyperglycemic agent that improves glucose tolerance in patients with type 2 diabetes, lowering both basal and postprandial plasma glucose. Metformin hydrochloride decreases hepatic glucose production, decreases intestinal absorption of glucose, and improves insulin sensitivity by increasing peripheral glucose uptake and utilization.


Side effects

Adverse events associated with the use of Metaglip may include (but are not limited to) the following:

  • Upper respiratory infection
  • Diarrhea
  • Dizziness
  • Hypertension
  • Nausea/vomiting
  • Headache
  • Musculoskeletal pain
  • Abdominal pain
  • Urinary tract infection

Treatment

Type 2 Diabetes

Select an option ICD-9 and ICD-10 ICD-9CM ICD-10CM Back News | Share | Print Picato (ingenol mebutate) gel Select an option ICD-9 and ICD-10 ICD-9CM ICD-10CM Back News | Share | Print Rapivab (peramivir injection) Select an option ICD-9 and ICD-10 ICD-9CM ICD-10CM Back News | Share | Print Rexulti (brexpiprazole) Select an option ICD-9 and ICD-10 ICD-9CM ICD-10CM Back News | Share | Print Prevnar 13 (Pneumococcal 13-valent Conjugate Vaccine) Select an option ICD-9 and ICD-10 ICD-9CM ICD-10CM Back News | Share | Print Condylox Gel 0.5% (pokofilox) Select an option ICD-9 and ICD-10 ICD-9CM ICD-10CM Back News | Share | Print Tecentriq (atezolizumab) Select an option ICD-9 and ICD-10 ICD-9CM ICD-10CM Back News | Share | Print Azor (amlodipine besylate; olmesartan medoxomil) Select an option ICD-9 and ICD-10 ICD-9CM ICD-10CM Back News | Share | Print PhosLo Select an option ICD-9 and ICD-10 ICD-9CM ICD-10CM Back News | Share | Print Diovan (valsartan) Select an option ICD-9 and ICD-10 ICD-9CM ICD-10CM Back News | Share | Print Plenaxis (abarelix for injectable suspension) Select an option ICD-9 and ICD-10 ICD-9CM ICD-10CM Back News | Share | Print Restasis (cyclosporine ophthalmic emulsion) Select an option ICD-9 and ICD-10 ICD-9CM ICD-10CM Back News | Share | Print Renagel (sevelamer hydrochloride) Select an option ICD-9 and ICD-10 ICD-9CM ICD-10CM Back News | Share | Print Acular (ketorolac tromethamine ophthalmic solution) 0.5% Select an option ICD-9 and ICD-10 ICD-9CM ICD-10CM Back News | Share | Print Ranexa (ranolazine) Select an option ICD-9 and ICD-10 ICD-9CM ICD-10CM Back News | Share | Print Proleukin Select an option ICD-9 and ICD-10 ICD-9CM ICD-10CM Back News | Share | Print Fycompa (perampanel) Select an option ICD-9 and ICD-10 ICD-9CM ICD-10CM Back News | Share | Print Valstar Select an option ICD-9 and ICD-10 ICD-9CM ICD-10CM Back News | Share | Print Procanbid (procainamide hydrochloride extended-release tablets) Select an option ICD-9 and ICD-10 ICD-9CM ICD-10CM Back News | Share | Print Rapamune (sirolimus) oral solution Select an option ICD-9 and ICD-10 ICD-9CM ICD-10CM Back News | Share | Print AneuVysion Assay Select an option ICD-9 and ICD-10 ICD-9CM ICD-10CM Back News | Share | Print Belviq (lorcaserin hydrochloride) Select an option ICD-9 and ICD-10 ICD-9CM ICD-10CM Back News | Share | Print Tykerb (lapatinib) Select an option ICD-9 and ICD-10 ICD-9CM ICD-10CM Back News | Share | Print Bexxar Select an option ICD-9 and ICD-10 ICD-9CM ICD-10CM Back News | Share | Print Zithromax (azithromycin) Select an option ICD-9 and ICD-10 ICD-9CM ICD-10CM Back News | Share | Print Tafinlar (dabrafenib) Select an option ICD-9 and ICD-10 ICD-9CM ICD-10CM Back News | Share | Print ReoPro Select an option ICD-9 and ICD-10 ICD-9CM ICD-10CM Back News | Share | Print Akynzeo (netupitant and palonosetron) Select an option ICD-9 and ICD-10 ICD-9CM ICD-10CM Back News | Share | Print Priftin Select an option ICD-9 and ICD-10 ICD-9CM ICD-10CM Back News | Share | Print Lovenox (enoxaparin sodium) Injection Select an option ICD-9 and ICD-10 ICD-9CM ICD-10CM Back News | Share | Print Omontys (peginesatide) Select an option ICD-9 and ICD-10 ICD-9CM ICD-10CM Back News | Share | Print Makena (hydroxyprogesterone caproate injection) Select an option ICD-9 and ICD-10 ICD-9CM ICD-10CM Back News | Share | Print Pravachol (pravastatin sodium) Select an option ICD-9 and ICD-10 ICD-9CM ICD-10CM Back News | Share | Print Prolia (denosumab) Select an option ICD-9 and ICD-10 ICD-9CM ICD-10CM Back News | Share | Print Xtoro (finafloxacin otic suspension) 0.3% Select an option ICD-9 and ICD-10 ICD-9CM ICD-10CM Back News | Share | Print Curosurf Select an option ICD-9 and ICD-10 ICD-9CM ICD-10CM Back News | Share | Print AlphaNine SD Coagulation Factor IX (Human) Select an option ICD-9 and ICD-10 ICD-9CM ICD-10CM Back News | Share | Print Busulflex Select an option ICD-9 and ICD-10 ICD-9CM ICD-10CM Back News | Share | Print Rytary (carbidopa and levodopa) extended-release capsules Select an option ICD-9 and ICD-10 ICD-9CM ICD-10CM Back News | Share | Print Orencia (abatacept) Select an option ICD-9 and ICD-10 ICD-9CM ICD-10CM Back News | Share | Print Redux (dexfenfluramine hydrochloride)